Evidence map›Paper›PMID 34795761›Full record

ReviewInternational journal of dentistry2021

Potential of Bone-Marrow-Derived Mesenchymal Stem Cells for Maxillofacial and Periodontal Regeneration: A Narrative Review.

Hamid Reza Khorasani, Mahboubeh Sanchouli, Javad Mehrani, Davood Sabour

Abstract readReview
In one paragraph

Review in International journal of dentistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Frontiers in bioengineering and biotechnology · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. A ComparativeFrontiers in cell and developmental biology · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hamid Reza KhorasaniDepartment of Cancer Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Isar 11, 47138-18983 Babol, Iran.ORCID https://orcid.org/0000-0001-6124-7056
Mahboubeh SanchouliDepartment of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Ganjafrooz Str, 47176-47745 Babol, Iran.ORCID https://orcid.org/0000-0003-2090-9011
Javad MehraniDepartment of Periodontics, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-7381-3091
Davood SabourDepartment of Cancer Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Isar 11, 47138-18983 Babol, Iran.ORCID https://orcid.org/0000-0003-0552-8931

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone-marrow-derived mesenchymal stem cells (BM-MSCs) are one of the most widely studied postnatal stem cell populations and are considered to utilize more frequently in cell-based therapy and cancer. These types of stem cells can undergo multilineage differentiation including blood cells, cardiac cells, and osteogenic cells differentiation, thus providing an alternative source of mesenchymal stem cells (MSCs) for tissue engineering and personalized medicine. Despite the ability to reprogram human adult somatic cells to induced pluripotent stem cells (iPSCs) in culture which provided a great opportunity and opened the new door for establishing the

Identifiers

PMID34795761
PMCPMC8594991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.